- Filed
- May 8, 2015 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2015 · May 5, 2015 | 73.75M sh |
| Shares Diluted | Q3 2015 · Mar 31, 2015 | 73.88M sh |
| Shares Diluted | Q3 2015 · Mar 31, 2015 | 73.89M sh |
| Shares Diluted | Q3 2015 · Mar 31, 2014 | 74.43M sh |
| Shares Diluted | Q3 2015 · Mar 31, 2014 | 75.07M sh |
| Stock Repurchased | Q3 2015 · Mar 31, 2015 | $242K |
| Stock Repurchased | Q3 2015 · Mar 31, 2014 | $26.61M |
| Capex | Q3 2015 · Mar 31, 2015 | $41.16M |
| Capex | Q3 2015 · Mar 31, 2014 | $28.02M |
| Short Term Debt | Q3 2015 · Mar 31, 2015 | $656K |
| Short Term Debt | Q3 2015 · Jun 30, 2014 | $59K |
| Cash And Equivalents | Q3 2015 · Mar 31, 2015 | $72.07M |
| Cash And Equivalents | Q3 2015 · Jun 30, 2014 | $97.79M |
| Cash And Equivalents | Q3 2015 · Mar 31, 2014 | $112.92M |
| Cash And Equivalents | Q3 2015 · Jun 30, 2013 | $169.68M |
| Stockholders Equity | Q3 2015 · Mar 31, 2015 | $430.09M |
| Stockholders Equity | Q3 2015 · Jun 30, 2014 | $435.23M |
| Current Liabilities | Q3 2015 · Mar 31, 2015 | $88.81M |
| Current Liabilities | Q3 2015 · Jun 30, 2014 | $97.98M |
| Total Liabilities | Q3 2015 · Mar 31, 2015 | $284.16M |
| Total Liabilities | Q3 2015 · Jun 30, 2014 | $324.6M |
| Current Assets | Q3 2015 · Mar 31, 2015 | $297.06M |
| Current Assets | Q3 2015 · Jun 30, 2014 | $323.25M |
| Total Assets | Q3 2015 · Mar 31, 2015 | $799.7M |
| Total Assets | Q3 2015 · Jun 30, 2014 | $845.13M |
| Eps Diluted | Q3 2015 · Mar 31, 2015 | $0.10 |
| Eps Diluted | Q3 2015 · Mar 31, 2015 | $0.40 |
| Eps Diluted | Q3 2015 · Mar 31, 2014 | $0.02 |
| Eps Diluted restated | Q3 2015 · Mar 31, 2014 | $0.21 |
| Eps Basic | Q3 2015 · Mar 31, 2015 | $0.10 |
| Eps Basic | Q3 2015 · Mar 31, 2015 | $0.40 |
| Eps Basic | Q3 2015 · Mar 31, 2014 | $0.02 |
| Eps Basic restated | Q3 2015 · Mar 31, 2014 | $0.21 |
| Sga Expense | Q3 2015 · Mar 31, 2015 | $25.01M |
| Sga Expense | Q3 2015 · Mar 31, 2015 | $63.6M |
| Sga Expense | Q3 2015 · Mar 31, 2014 | $23.39M |
| Sga Expense | Q3 2015 · Mar 31, 2014 | $75.03M |
| Net Income | Q3 2015 · Mar 31, 2015 | $7.72M |
| Net Income | Q3 2015 · Mar 31, 2015 | $29.4M |
| Net Income | Q3 2015 · Mar 31, 2014 | $1.56M |
| Net Income restated | Q3 2015 · Mar 31, 2014 | $15.48M |
| Operating Income | Q3 2015 · Mar 31, 2015 | $15.85M |
| Operating Income | Q3 2015 · Mar 31, 2015 | $55M |
| Operating Income | Q3 2015 · Mar 31, 2014 | $7.74M |
| Operating Income | Q3 2015 · Mar 31, 2014 | −$4.06M |
| Cost Of Revenue | Q3 2015 · Mar 31, 2015 | $153.79M |
| Cost Of Revenue | Q3 2015 · Mar 31, 2015 | $480.16M |
| Cost Of Revenue | Q3 2015 · Mar 31, 2014 | $164.93M |
| Cost Of Revenue | Q3 2015 · Mar 31, 2014 | $467.92M |